Buy CytoSorbents Stock | CTSO Stock Price & Latest News | Public.com
CTSO

CytoSorbents

$0.00 (0.00%)Today
    View CytoSorbents (CTSO) stock trends here

    About CTSO

    CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on A...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.03
    -0.01
    -0.04
    -0.08
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $0.03

    Actual EPS
    Q1 2021

    Stats

    Market Cap$406,71M
    Volume291,33k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.74
    1 Year Low$3.60
    Open$9.71
    High$9.95
    Low$9.39

    Buy any stock with any amount of money.

    Download the App
    Download the app